pharma · Scabies · Bioequivalence trial in healthy volunteers
Alphapharm
Alphapharm Pty Ltd
Alphapharm Pty is a pharma organization headquartered in AU. Primary therapeutic focus areas include Scabies, Bioequivalence trial in healthy volunteers, moderate to severely inflamed candidiasis of the skin, Mild to mod
Company details
- Status
- Public
- HQ
- Level 1, 30 The Bond, 30-34 Hickson Road, Millers Point, NSW 2000, AU
- Founded
- 1982
- Employees
- 187
- Programs
- 30
- Drugs
- 235
- Patents
- 12
Debio 0123-102
Phase 1 · other · Arm A: Diagnosed with uterine serous carcinoma (USC) Arm B: Diagnosed with recurrent or progressive, high-grade epithelial ovarian cancer (EOC) with cyclin E1-driven selection Arm C: Diagnosed with solid tumor with biomarker-driven selection
Debio 0123-102 for Arm A: Diagnosed with uterine serous carcinoma (USC) Arm B: Diagnosed with recurrent or progressive, high-grade epithelial ovarian cancer (EOC) with cyclin E1-driven selection Arm C: Diagnosed with solid tumor with biomarker-driven selection is a Phase 1 program (other) at Alphapharm Pty Ltd with 1 ClinicalTrials.gov record(s).
Internal code Debio 0123-102
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Alphapharm Pty Ltd
- Phase
- Phase 1
- Modality
- other
- Indication
- Arm A: Diagnosed with uterine serous carcinoma (USC) Arm B: Diagnosed with recurrent or progressive, high-grade epithelial ovarian cancer (EOC) with cyclin E1-driven selection Arm C: Diagnosed with solid tumor with biomarker-driven selection
- Status
- active
- Trials
- 1